| mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
0.024 |
0.9 |
| mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.9 |
| mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
-0.0083 |
0.9 |
| mRNA |
Bexarotene |
FIMM |
pan-cancer |
AAC |
-0.023 |
0.9 |